Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction
about
Oncogene proteins and proliferation antigens in thymomas: increased expression of epidermal growth factor receptor and Ki67 antigenTargeting epidermal growth factor receptor: novel therapeutics in the management of cancer.Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines.Molecular therapy of head and neck cancer.A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage-independent growth of breast cancer cell lines.Phase I trial and tumour localisation of the anti-EGFR monoclonal antibody ICR62 in head and neck or lung cancerIn vivo pharmacology and anti-tumour evaluation of the tyrphostin tyrosine kinase inhibitor RG13022.The transcription factor AP-1 is required for EGF-induced activation of rho-like GTPases, cytoskeletal rearrangements, motility, and in vitro invasion of A431 cells.Growth inhibition of human lung adenocarcinoma cells by antibodies against epidermal growth factor receptor and by ganglioside GM3: involvement of receptor-directed protein tyrosine phosphatase(s).Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats.Preclinical models for the evaluation of targeted therapies of metastatic disease.Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity.Epidermal growth factor receptor expression by human squamous cell carcinomas of the head and neck, cell lines and xenografts.Cooperative inhibition of renal cancer growth by anti-epidermal growth factor receptor antibody and protein kinase A antisense oligonucleotide.
P2860
Q28389449-1C5DBC7F-8432-46BD-9CDE-BDB38155594AQ35160217-8D3ADC94-62D6-4CA4-A1C3-54058C622A1FQ35978088-C35840B5-1F31-4224-9050-42204E1D4AF3Q36078112-7E1797CE-EDAB-41EC-999C-93680DE0C8ADQ36079584-93F9CD24-0EFE-4C2E-A12D-A822BF18A7AEQ36134525-E77551C3-DF28-447C-A25E-0DACC2A12641Q36141225-CAA7EEA9-DD8F-4A09-ABE7-C8DEC38BCA6FQ36255893-426B947F-70DA-49CD-A862-3B634EA83861Q39713075-36473B6E-0F88-4F61-BD3B-24F5C4E85190Q40201980-02F9C820-D7A7-46A4-BC43-DC89663A6303Q40517112-5237C9B2-F9AD-4A94-86A6-4574B9E5BF0CQ41887619-BF27D21C-BE55-4877-885B-9A7312C23415Q42497044-827B1453-62CE-4211-85BE-1BEC644A7C7DQ47808995-7960D07B-7B0D-44ED-91AF-33E0B221C79E
P2860
Immunotherapy of human tumour xenografts overexpressing the EGF receptor with rat antibodies that block growth factor-receptor interaction
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Immunotherapy of human tumour ...... th factor-receptor interaction
@ast
Immunotherapy of human tumour ...... th factor-receptor interaction
@en
type
label
Immunotherapy of human tumour ...... th factor-receptor interaction
@ast
Immunotherapy of human tumour ...... th factor-receptor interaction
@en
prefLabel
Immunotherapy of human tumour ...... th factor-receptor interaction
@ast
Immunotherapy of human tumour ...... th factor-receptor interaction
@en
P2093
P2860
P921
P356
P1476
Immunotherapy of human tumour ...... th factor-receptor interaction
@en
P2093
P2860
P2888
P304
P356
10.1038/BJC.1993.49
P407
P577
1993-02-01T00:00:00Z